January Investment Update
Released
Released
Announcement PDF
Monthly Investment Update
January 2024
7 February 2024
The Manager
ASX Market Announcements
ASX Limited
Exchange Centre
Level 4, 20 Bridge Street
Sydney NSW 2000
Dear Shareholders,
Please find attached Hearts and Minds Investments Limited’s January Investment Update.
If you would like to receive these monthly investment updates via email please subscribe here.
For and on behalf of the board,
Tom Bloomfield
Company Secretary
Hearts and Minds Investments Limited ACN 628 753 220
A: 12.04A Chifley Tower, 2 Chifley Square, Sydney NSW 2000 | W: HM1.com.au | E: ir@hm1.com.au | P: 1300 737 760 or +61 2 9290 9600
Monthly Investment Update
January 2024
Investment Objective
Provide a concentrated portfolio of long-only positions in 25-35
Australian and global securities based on the highest conviction
ideas from respected fund managers. The Company forgoes any
investment fees and instead donates to leading Australian
medical research institutes.
Pre-Tax NTA
$3.00
Post-Tax NTA
$3.01
Share Price
$2.63
Portfolio Commentary
Markets continued to rally in January 2024 spurred mostly by
US tech stocks resulting in double digit gains over the past 3
months across most market indices. For January 2024, the S&P
500 increased 3.0%, and the Nasdaq increased 2.7% and the
ASX 200 up 1.2%. The Australian dollar weakened 3% to
US$0.657 which boosted the increase in the MSCI World Index
in AUD which was up 4.8% in January. The HM1 portfolio
continued to perform well in January up 3.0% and up 13.2%
over the past 3 months. Since inception in November 2018, the
HM1 portfolio has delivered an annualised pre-tax investment
return of 9.0% pa and has paid dividends totalling 46 cents per
share.
The portfolio generally performed well in January. Nvidia was
the standout rising 24% alongside our other chip manufacturer
TSMC which was up 9%. In the case of Nvidia, earnings have
been rising even faster than the share price as the company has
seen exponential demand for its AI enabling semiconductors.
Also performing well for the month were ResMed (+11%), Telix
(+14%) and NexGen (+11%). On the downside, Miniso Group
fell 19% as the whole China listed equity market continued to
underperform.
This month we take a deep dive into one of our conference
stocks within the portfolio that was astutely picked by Chris
Kourtis of Ellerston Capital. ResMed was up 11% in January and
is up 26% since our purchase in November. You can read more
here.
(ASX: HM1)
Investment Performance p.a.
(Since inception 14 Nov 2018)
Latest Dividend
(Interim paid 19 October 2023)
Fully Franked Dividend Yield1
9.0%
7cps
5.1%
Cash Weighting
4%
Profits Reserve
49cps
(At 31 December 2023)
Available Franking Credits2
(At 31 December 2023)
Cumulative Medical Research Funding
56cps
$43.9m
1 Fully franked dividend of 13.5cps divided by share price at 31 January 2024. 2 Represents the level of future dividends (expressed as cents per share) that can be fully franked. All
figures as at 31 January 2024 unless otherwise stated. Fund inception 14 Nov 2018. This communication has been prepared by Hearts and Minds Investments Limited (ABN 61 628 753
220). In preparing this document the investment objectives, financial situation or particular needs of an individual have not been considered. You should not rely on the opinions,
advice, recommendations and other information contained in this publication alone. This publication has been prepared to provide you with general information only. It is not
intended to take the place of professional advice and you should not take action on specific issues in reliance on this information. Past performance is not a reliable indicator of future
performance.
Monthly Investment Update
January 2024
HM1 Investment Performance
1 month
6 months
1 year
3 years
per annum
HM1 Investment Performance
3.0%
3.4%
7.0%
-4.7%
Since Inception
per annum
9.0%
MSCI World Index (AUD)
4.8%
6.6%
23.0%
11.7%
11.1%
Investment Performance
HM1 Investment Performance is calculated after expenses and before taxes. The comparator is the MSCI World price index in AUD. Source: Citco Fund Services and
www.msci.com. Inception 14 Nov 2018.
Dividend History
Dividend History
2021
2022
2023
Dividends – fully franked
12cps
13.5cps
13.5cps
2024
(Interim)
7.0cps
Top 10 Portfolio Holdings
Represents 48% of total portfolio holdings (in alphabetical order)
Conference Portfolio Holdings
Represents 31% of total portfolio holdings (in alphabetical order)
All figures as at 31 January 2024 unless otherwise stated. Fund inception 14 Nov 2018. This communication has been prepared by Hearts and Minds Investments Limited (ABN 61 628
753 220). In preparing this document the investment objectives, financial situation or particular needs of an individual have not been considered. You should not rely on the opinions,
advice, recommendations and other information contained in this publication alone. This publication has been prepared to provide you with general information only. It is not
intended to take the place of professional advice and you should not take action on specific issues in reliance on this information. Past performance is not a reliable indicator of future
performance.
Monthly Investment Update
January 2024
News from the HM1 Network
In this month’s update, we
spotlight one of our conference
stocks RedMed. ResMed was one
of our high conviction stocks
pitched by Chris Kourtis of
Ellerston Capital at the 2023 Sohn
Hearts & Minds Conference. You
can learn more here.
Although there may still be some
volatility in the near term, our
Core Fund Manager, Munro
Partners sees many reasons to be
optimistic in the medium term.
Discover their outlook for the new
year including their insights on
emerging winners. Read the article
on Livewire here.
Arvid Streimann and Nikki
Thomas, of Magellan (Core Fund
Manager) share insights on the
investment attributes that led the
market in 2023 and the key
thematics to watch out for in the
year ahead. You can watch the
video here.
Congratulations to Co-Founder
and Director, Guy Fowler OAM,
on being honoured with the Medal
of the Order of Australia (OAM) for
his service to business and the
community. Guy recently shared
insights with The Australian about
the establishment of Hearts &
Minds. You can learn more here.
Congratulations to Prof Sally
Dunwoodie AO who has been
honoured with an Officer of the
Order of Australia (AO). It's a
testament to her world-leading
research in the field of congenital
heart disease. You can learn more
about her research here.
Discover the behind-the-scenes
magic of putting together the Sohn
Hearts & Minds Conference from
Jonathan Pease, our founding
Creative Director, and author of
‘Winning
the
Room’.
In
conversation with Mark Bouris,
Jonathan also shares actionable
insights for mastering the perfect
pitch or presentation. You can
listen to the podcast episode here.
Prof Daniel MacArthur, Director
of the Centre for Population
Genomics has big goals to bring
equity and diversity into genomic
medicine in Australia. Tune into
this interesting Medical Minds
episode to learn more about his
work. You can listen here.
Congratulations to our Director,
Lorraine Berends AM, for being
honoured with the Member of the
Order of Australia (AM). Lorraine
has been a champion for Women
in Finance and a great mentor to
many young professionals. Read
more about her journey here.
Core Fund Manager, Regal Funds
Management was crowned for
their small-cap fund as the No.1
performing Australian equities
fund in 2023. Todd Guyot, coportfolio manager, Philip King and
James Sioud, were interviewed
by The Australian Financial Review.
You can read the full article here.
Disclaimer: This communication has been prepared by Hearts and Minds Investments Limited (ABN 61 628 753 220) and may contain general information relating to HM1
securities. The general information should not be considered financial advice. HM1 is not licensed to provide financial product advice. The information does not consider the
investment objectives, financial situation, or particular needs of any individual. The information is current as at the date of preparation and is subject to change. HM1 does not
guarantee repayment of capital or any rate of return on HM1 securities. An investment may achieve a lower-than-expected return and investors risk losing some, or all, of their
principal investment. Past performance is not a reliable indicator of future performance. This document may not be reproduced or copies circulated without prior authority from
Hearts and Minds Investments Limited.
Monthly Investment Update
January 2024
Core Fund Managers
Conference Fund Managers
Designated Beneficiaries
Pro-Bono Service Providers
Disclaimer: This communication has been prepared by Hearts and Minds Investments Limited (ABN 61 628 753 220) and may contain general information relating to HM1 securities. The general
information should not be considered financial advice. HM1 is not licensed to provide financial product advice. The information does not consider the investment objectives, financial situation, or
particular needs of any individual. The information is current as at the date of preparation and is subject to change. HM1 does not guarantee repayment of capital or any rate of return on HM1
securities. An investment may achieve a lower-than-expected return and investors risk losing some, or all, of their principal investment. Past performance is not a reliable indicator of future
performance. This document may not be reproduced or copies circulated without prior authority from Hearts and Minds Investments Limited.
Share your feedback
Discover